Position in GALT
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$83,700
New position
Shares Held
30,000
first reported quarter
Ownership
0.046%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pekin Hardy Strauss, Inc. holds $3,625,786 across 6 Biotechnology names. GALT ranks #4 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QURE |
uniQure N.V.
|
112,575 | $1,840,601 | |
| 2 | ARDX |
Ardelyx, Inc.
|
255,800 | $1,532,242 | |
| 3 | CRMD |
CorMedix Inc.
|
18,000 | $122,220 | |
| 4 | GALT |
Galectin Therapeutics Inc
This page
|
30,000 | $83,700 | |
| 5 | DYAI |
Dyadic International Inc
|
41,745 | $34,230 | |
| 6 | HRTX |
Heron Therapeutics, Inc. /De/
|
15,992 | $12,793 |
All Filings in GALT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $83,700 | 30,000 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||